aldose reductase inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namealdose reductase inhibitors (Pfizer)
Drug Alias NameCP-744809ARI-809
ClassificationSmall molecules
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetes ComplicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A